JPIAMR, the Joint Programming Initiative on Antimicrobial Resistance, published its 6th call “New Targets, Compounds and Tools”. To date fifteen countries are participating with a total budget of approximately 13 million Euros.
EU-OPENSCREEN warmly welcomes consortia bidding for the JPIAMR call to come and discuss how our respective organisations might cooperate. Please email us at email@example.com for more information.
Proposals responding to the call must include research on Mycobacterium tuberculosis or a priority pathogen on the WHO PPL. The proposal can address the following topics:
• NEW TARGETS/MECHANISMS: Studies of new bacterial targets or mechanisms of resistance (examples include studies on novel enzyme or efflux pump inhibitors or others), including studies aimed at understanding and overcoming the mechanisms controlling the generation of resistance.
• NEW THERAPIES: Studies of new compounds (including new antibiotics and alternatives). Strategies to inhibit or reduce the acquisition of resistance, such as single molecular agents effective against multiple targets as well as therapeutics that enhance immune-mediated pathogen elimination, disrupt colonisation or biofilm development, and reduce virulence. Discovery of novel therapies to overcome known antimicrobial resistance mechanisms and/or to restore susceptibility to conventional antibiotics.
• NEW STRATEGIES/TOOLS/ASSAYS: That improve, enhance, and/or facilitate the identification or validation of new effective compounds or therapies. For optimisation of drug use, dosage and delivery of new drugs. Exploring bacterial genes, e.g. expression of latent gene clusters.
The submission deadline for pre-proposals will be in March 2018, full proposal invitations must be sent to the project coordinators by May 2018 and the submission deadline for full proposals will be in June 2018.